Vaxcyte, Inc. Common Stock PCVX

$66.70 -9.65% at last close

Recent SEC Filings

FormDescriptionFiledDocument
424B5 424B5 2026-10-06 View →
424B5 424B5 2026-10-06 View →
8-K 8-K 2026-10-05 View →
4 FORM 4 2026-10-02 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
4 FORM 4 2026-09-09 View →
8-K 8-K 2026-09-03 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-09-02 View →
4 FORM 4 2026-08-05 View →
4 FORM 4 2026-08-05 View →
4 FORM 4 2026-08-05 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-07-16 View →
8-K 8-K 2026-07-15 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-06-26 View →
4 FORM 4 2026-06-23 View →
8-K 8-K 2026-06-23 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
4 FORM 4 2026-06-16 View →
8-K 8-K 2026-06-16 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$66.70
Market Cap
$10.98 billion
52-Week Range
$30.81 – $90.75
Average Volume
2.11 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.